Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin + 5-FU/LV in Unresectable Hepatocellular Carcinoma
NCT00559455Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Jan 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by Sanofi. Started Sep 2007; status: completed.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00559455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559455.